Andrew T. Parsa MD, PhD, describes the development and trial involving prophage G-200, a vaccine for recurrent glioblastoma multiforme.
Researchers Identify How Nongenetic Mechanisms of Cancer Cell Diversity Can Affect Treatment Response
Seth A. Wander, MD, PhD; Girish Kunapareddy, MD
Virginia Kaklamani, MD, DSc; Jack W. Erter III, MD, MMHC
2 Sessions are Available!
Seth A. Wander, MD, PhD; Kit Lu, MD
May 22, 2026
Neil M. Iyengar, MD; Kimberly Ku, MD
Sheila Donnelly, MD; Virginia Kaklamani, MD, DSc
May 27, 2026
Reshma Jagsi, MD, DPhil; Kevin Kalinsky, MD, MS; Hope S. Rugo, MD, FASCO; Alastair Thompson, MD, MBChB, BSc (Hons), FRCS (Ed), FACS
May 29-31, 2026
Seth A. Wander, MD, PhD; Kamel Abou Hussein, MD
Alison K. Conlin, MD; Neil M. Iyengar, MD
June 8, 2026
Yan Ji, MD; Neil M. Iyengar, MD
Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH
1 Session is Available!
Seth A. Wander, MD, PhD; Ruta D. Rao, MD
Marla D. Lipsyc-Sharf, MD; Richard Zelkowitz, MD
Seth A. Wander, MD, PhD; Kate Baxstrom, MD
William J. Gradishar, MD, FASCO, FACP; Laura Huppert, MD; Yuan Yuan, MD, PhD
Aditya Bardia, MD, MPH, FASCO; Joyce O’Shaughnessy, MD; Hope S. Rugo, MD; Paolo Tarantino, MD
July 10-11, 2026
Joyce O’Shaughnessy, MD; Matthew P. Goetz, MD; Hope S. Rugo, MD, FASCO
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc
Virginia Kaklamani, MD, DSc; Tiffany A. Traina, MD, FASCO
Filipa Lynce, MD; Rita Nanda, MD
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD
Joyce O’Shaughnessy, MD
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Virginia Kaklamani, MD, DSc; Filipa Lynce, MD; Rita Nanda, MD; Tiffany A. Traina, MD, FASCO
Aditya Bardia, MD, MPH, FASCO; Erika P. Hamilton, MD; Tiffany A. Traina, MD, FASCO
Ana C. Garrido-Castro, MD; Pedram Razavi, MD, PhD
Michelle L. Taylor, ANP-BC; Emely Alfaro, DNP, RN, CNS, OCN; Paige Griffith, CRNP; Beth Sandy, MSN, CRNP, FAPO
